Log In
Thursday 20th October 2016

Cutting-edge cancer services launched

26th June 2008

CancerPartners UK and leading private hospital provider Spire Healthcare this week announced a partnership that will see the organisation provide cutting edge cancer treatments on three Spire hospital sites - the first private radiotherapy services outside London.

Expanded cancer centres will be built on the Spire hospital sites in Leeds, Birmingham and Portsmouth to deliver state of the art radiotherapy services using  the latest generation technologies, including Intensity-Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT). These are shown to have significant benefits in treating some of the UK’s most common cancers including breast and prostate cancer.

CancerPartners UK was set up in 2006 with a view to introducing a new and innovative model of cancer care to the UK. The partnership with Spire, already one of the UK’s leading providers of oncology services, reflects the commitment of both organisations to invest in and improve cancer services across the country, whilst also addressing areas of unmet need as identified by the National Cancer Strategy and the National Radiotherapy Advisory Group (NRAG) and supported by data from the Swedish Karolinska Institute. 

Professor Karol Sikora, leading cancer specialist and Medical Director of CancerPartners UK, said:

“It is our philosophy to bring high quality cancer care closer to patients. This deal marks an important milestone for us, as we look to roll out cancer services across the country, and make cutting edge treatments and services available to increasing numbers of patients.
“This partnership will enable more patients to access the best in modern treatment, including much needed radiotherapy services – an area acknowledged in the Government’s Cancer Reform Strategy as being under-developed in the UK.��?

Richard Jones, Commercial Director of Spire Healthcare, said: “The new centres will offer the first fully-integrated private cancer treatment facilities in the UK outside London, bringing together the skills, technology and clinical ability to radically improve care and deliver world class treatment. They will let people access diagnostics, surgery, chemotherapy and radiotherapy all on one site in a comfortable, clean environment, giving patients rapid access to leading oncologists in the area.��?

The centres will be able to deliver treatment to patients just seven days after referral. Currently, many patients are waiting up to 50 days before receiving treatment. The first patient is expected be treated in the new cancer centres by July 2009. In the long term it is hoped that partnerships with local NHS bodies will widen access to this innovative treatment.

At the same time, CancerPartners UK announced an agreement with Bupa, the UK’s largest health insurer. Bupa will continue to support CancerPartners UK to deliver greater access to services and develop high-quality, affordable care for cancer patients.

CancerPartners UK was founded by Apposite Capital, a leading investment firm exclusively focused on healthcare.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016